Radcliffe Capital Management, L.P. - EUROPEAN BIOTECH ACQUTN CORP ownership

EUROPEAN BIOTECH ACQUTN CORP's ticker is EBACW and the CUSIP is G3167F128. A total of 1 filers reported holding EUROPEAN BIOTECH ACQUTN CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Radcliffe Capital Management, L.P. ownership history of EUROPEAN BIOTECH ACQUTN CORP
ValueSharesWeighting
Q4 2022$672,317
+1.7%
66,566
-0.2%
0.02%
+31.2%
Q3 2022$661,000
+1.2%
66,6660.0%0.02%
+6.7%
Q2 2022$653,000
+0.3%
66,6660.0%0.02%0.0%
Q1 2022$651,000
+0.6%
66,6660.0%0.02%
-11.8%
Q4 2021$647,000
-0.3%
66,6660.0%0.02%
-10.5%
Q3 2021$649,000
+0.3%
66,6660.0%0.02%
-5.0%
Q2 2021$647,00066,6660.02%
Other shareholders
EUROPEAN BIOTECH ACQUTN CORP shareholders Q3 2023
NameSharesValueWeighting ↓
ANGELO GORDON & CO., L.P. 13,333$132,0000.02%
Radcliffe Capital Management, L.P. 66,666$661,0000.02%
MARSHALL WACE, LLP 108,584$1,076,0000.00%
MMCAP International Inc. SPC 73,525$7,0000.00%
DIFESA CAPITAL MANAGEMENT, LP 14,159$1,0000.00%
WHITEBOX ADVISORS LLC 16,833$2,0000.00%
MILLENNIUM MANAGEMENT LLC 140,000$14,0000.00%
LINDEN ADVISORS LP 40,115$3,0000.00%
Calamos Advisors LLC 33,333$2,0000.00%
STATE OF WISCONSIN INVESTMENT BOARD 19,560$1,0000.00%
View complete list of EUROPEAN BIOTECH ACQUTN CORP shareholders